Resultados de procura - Sanson, M
- Mostrando 1 - 20 Resultados de 34
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
O8.08 CIC MUTATION IS A POOR PROGNOSIS FACTOR IN 1P19Q CODELETED GLIOMAS, ASSOCIATED TO AN UP-REGULATION OF PROLIFERATION PATHWAYS por Gleize, V., Alentorn, A., Connen de Kérillis, L., Labussière, M., Mangesius, S., Ducray, F., Mokhtari, K., Villa, C., Sanson, M.
Publicado 2014Text -
8
OS6.6 CEVOREM Trial: Combination of EVerolimus and Octreotide in REsistant MeningiomasPresentation and Preliminary results por Graillon, T., Peyre, M., Kalamarides, M., Sanson, M., Barrié, M., Campello, C., Tabouret, E., Roche, P., Dufour, H., Chinot, O.
Publicado 2016Text -
9
-
10
P08.63 Dose optimization of MK-8628 (OTX015), a small molecule inhibitor of bromodomain and extra-terminal (BET) proteins, in patients with recurrent glioblastoma por Hottinger, A. F., Sanson, M., Moyal, E., Delord, J., Rezai, K., Leung, A., Perez, S., Bekradda, M., Lachaux, N., Chinot, O.
Publicado 2016Text -
11
-
12
O6.08 COMBINED ANALYSIS OF TERT, EGFR AND IDH STATUS DEFINE DISTINCT PROGNOSTIC CLASSES OF GLIOBLASTOMA por Labussiere, M., Boisselier, B., Mokhtari, K., Di Stefano, A., Rahimian, A., Saulnier, O., Paterra, R., Finocchiaro, G., Marie, Y., Sanson, M.
Publicado 2014Text -
13
-
14
-
15
P06.18 DNA methylation distance score in lower-grade gliomas has prognostic value: a POLA network study por Alentorn, A., Kamoun, A., Ducray, F., Dehais, C., Mokhtari, K., Uro-Coste, E., Figarella-Branger, D., Delattre, J., Idbaih, A., Sanson, M.
Publicado 2016Text -
16
P07.15 Diagnostic value of 2-hydroxyglutarate detection by 1H MR spectroscopy in patients with glioma and correlations with tumor phenotype and tissue dosage por Di Stefano, A. L., Branzoli, F., Ottolenghi, C., Capelle, L., Mokhtari, K., Villa, C. M., Giry, M., Marjanska, M., Lehericy, S., Sanson, M.
Publicado 2016Text -
17
-
18
EH1.1 Results of the interim analysis of the EORTC randomized phase III CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q co-deletion, an int... por van den Bent, M. J., Erridge, S., Vogelbaum, M., Nowak, A., Sanson, M., Brandes, A. A., Golfinopoulos, V., Gorlia, T., Kros, J. M., Baumert, B. G.
Publicado 2016Text -
19
P01.12 Stability of actionable mutations in primary and recurrent glioblastomas por French, P. J., Taphoorn, M., Weyerbrock, A., Sanson, M., Hoeben, A., Lukavoca, S., Lombardi, G., Hanse, M., Watts, C., Golfinopoulos, V., McDermott, U., Robe, P.
Publicado 2017Text -
20
OS8.5 How to assess meningioma therapy activity: The CEVOREM independent central review experience por GRAILLON, T, Colin, T, Peyrière, H, Peyre, M, Tabouret, E, Campello, C, Idbaih, A, Boucekine, M, Figarella-Branger, D, Kalamarides, M, Dufour, H, Sanson, M, Chinot, O
Publicado 2019Text